Should patients with extrapulmonary small-cell carcinoma receive prophylactic cranial irradiation?

Hdl Handle:
http://hdl.handle.net/10147/302411
Title:
Should patients with extrapulmonary small-cell carcinoma receive prophylactic cranial irradiation?
Authors:
Naidoo, Jarushka; Teo, Min Yuen; Deady, Sandra; Comber, Harry; Calvert, Paula
Affiliation:
* Department of Medical Oncology, Waterford Regional Hospital, Waterford, Ireland; †Department of Medical Oncology, The Adelaide and Meath Hospital Tallaght, Dublin, Ireland; and ‡Department of Research and Data Analysis, National Cancer Registry of Ireland, Cork, Ireland.
Citation:
Should patients with extrapulmonary small-cell carcinoma receive prophylactic cranial irradiation? 2013, 8 (9):1215-21 J Thorac Oncol
Journal:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Issue Date:
Sep-2013
URI:
http://hdl.handle.net/10147/302411
DOI:
10.1097/JTO.0b013e31829f6b03
PubMed ID:
23945390
Abstract:
Extrapulmonary small-cell carcinoma (EPSCC) is a rare disease. Management is based on small-cell lung carcinoma. Prophylactic cranial irradiation (PCI) is not routinely administered in EPSCC. This study investigates the role of PCI in EPSCC, by analyzing the incidence, treatment, and survival of patients with brain metastases in a national cohort. Disease biology and epidemiology are also investigated.
Item Type:
Article
Language:
en
ISSN:
1556-1380

Full metadata record

DC FieldValue Language
dc.contributor.authorNaidoo, Jarushkaen_GB
dc.contributor.authorTeo, Min Yuenen_GB
dc.contributor.authorDeady, Sandraen_GB
dc.contributor.authorComber, Harryen_GB
dc.contributor.authorCalvert, Paulaen_GB
dc.date.accessioned2013-09-27T11:42:39Z-
dc.date.available2013-09-27T11:42:39Z-
dc.date.issued2013-09-
dc.identifier.citationShould patients with extrapulmonary small-cell carcinoma receive prophylactic cranial irradiation? 2013, 8 (9):1215-21 J Thorac Oncolen_GB
dc.identifier.issn1556-1380-
dc.identifier.pmid23945390-
dc.identifier.doi10.1097/JTO.0b013e31829f6b03-
dc.identifier.urihttp://hdl.handle.net/10147/302411-
dc.description.abstractExtrapulmonary small-cell carcinoma (EPSCC) is a rare disease. Management is based on small-cell lung carcinoma. Prophylactic cranial irradiation (PCI) is not routinely administered in EPSCC. This study investigates the role of PCI in EPSCC, by analyzing the incidence, treatment, and survival of patients with brain metastases in a national cohort. Disease biology and epidemiology are also investigated.en_GB
dc.language.isoenen
dc.rightsArchived with thanks to Journal of thoracic oncology : official publication of the International Association for the Study of Lung Canceren_GB
dc.titleShould patients with extrapulmonary small-cell carcinoma receive prophylactic cranial irradiation?en_GB
dc.typeArticleen
dc.contributor.department* Department of Medical Oncology, Waterford Regional Hospital, Waterford, Ireland; †Department of Medical Oncology, The Adelaide and Meath Hospital Tallaght, Dublin, Ireland; and ‡Department of Research and Data Analysis, National Cancer Registry of Ireland, Cork, Ireland.en_GB
dc.identifier.journalJournal of thoracic oncology : official publication of the International Association for the Study of Lung Canceren_GB
dc.description.fundingNo fundingen
dc.description.provinceMunsteren
dc.description.peer-reviewpeer-reviewen

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.